• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的胱抑素C免疫比浊法。

Improved immunoturbidimetric assay for cystatin C.

作者信息

Lewis A V, James T J, McGuire J B, Taylor R P

机构信息

Department of Clinical Biochemistry, Oxford Radcliffe Hospital, Headington, UK.

出版信息

Ann Clin Biochem. 2001 Mar;38(Pt 2):111-4. doi: 10.1258/0004563011900399.

DOI:10.1258/0004563011900399
PMID:11269749
Abstract

An immunoturbidimetric assay for cystatin C was optimized with respect to assay imprecision. After investigating the optimum pH, polyethylene glycol concentration and specimen volume, two modifications were introduced: an increase in specimen volume to 25 microL; and an extension of the pre-incubation period to 240 s. These modifications produced an assay with between-batch imprecision (coefficient of variation, n = 10 or 11) ranging from 3-9% at 0.72 mg/L to 1.3% at 5.29 mg/L. The assay was susceptible to interference from lipaemia and haemolysis but not bilirubinaemia in both the original and modified protocol. Extending the pre-incubation to 240 s improved tolerance to common interferences and retained assay applicability in the routine clinical setting.

摘要

针对胱抑素C的免疫比浊法在检测不精密度方面进行了优化。在研究了最佳pH值、聚乙二醇浓度和样本体积后,引入了两项改进措施:将样本体积增加到25微升;将预孵育时间延长至240秒。这些改进使该检测方法的批间不精密度(变异系数,n = 10或11)在0.72毫克/升时为3%-9%,在5.29毫克/升时为1.3%。在原始方案和改进方案中,该检测方法均易受脂血和溶血的干扰,但不受黄疸的干扰。将预孵育时间延长至240秒提高了对常见干扰的耐受性,并在常规临床环境中保留了检测方法的适用性。

相似文献

1
Improved immunoturbidimetric assay for cystatin C.改良的胱抑素C免疫比浊法。
Ann Clin Biochem. 2001 Mar;38(Pt 2):111-4. doi: 10.1258/0004563011900399.
2
Improved assay characteristics of an immunoturbidimetric assay for cystatin C.
Ann Clin Biochem. 2001 Mar;38(Pt 2):153.
3
Correction to 'improved immunoturbidimetric assay for cystatin C'.
Ann Clin Biochem. 2001 Sep;38(Pt 5):572-3. doi: 10.1177/000456320103800520.
4
Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate.采用快速、自动化的颗粒增强比浊法测定的血清胱抑素C,对于肾小球滤过率而言,是比血清肌酐更好的标志物。
Clin Chem. 1994 Oct;40(10):1921-6.
5
Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C.用于人胱抑素C常规检测的定量自动化颗粒增强免疫比浊法。
Clin Chem Lab Med. 1998 Nov;36(11):859-65. doi: 10.1515/CCLM.1998.151.
6
Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Hitachi 917 analyzer.日立917分析仪上颗粒增强比浊法检测胱抑素C的性能评估。
Clin Chim Acta. 2008 Dec;398(1-2):75-7. doi: 10.1016/j.cca.2008.08.016. Epub 2008 Aug 23.
7
Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II).使用贝林散射比浊仪系统(BNA、BN II)通过颗粒增强免疫比浊法对胱抑素 C 测量进行初步评估。
Clin Chem. 1997 Jun;43(6 Pt 1):1016-22.
8
Adult cystatin C reference intervals determined by nephelometric immunoassay.通过散射比浊免疫分析法测定的成人胱抑素C参考区间。
Clin Biochem. 2007 Sep;40(13-14):1084-7. doi: 10.1016/j.clinbiochem.2007.05.011. Epub 2007 Jun 8.
9
Immunoturbidimetric assay for serum cystatin C using the Cobas Fara analyzer.使用Cobas Fara分析仪进行血清胱抑素C的免疫比浊法测定。
Clin Chem Lab Med. 2002 Aug;40(8):853-4. doi: 10.1515/CCLM.2002.150.
10
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.在雅培Ci8200上对龙胆胱抑素C试剂进行评估,并根据胱抑素C值(单位为mg/L)计算以mL/min/1.73 m²表示的肾小球滤过率。
Scand J Clin Lab Invest. 2007;67(5):560-7. doi: 10.1080/00365510601187773.

引用本文的文献

1
Cohort Profile: The Center for cArdiometabolic Risk Reduction in South Asia (CARRS).队列简介:南亚心血管代谢风险降低中心(CARRS)。
Int J Epidemiol. 2022 Dec 13;51(6):e358-e371. doi: 10.1093/ije/dyac014.
2
Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries.静脉输注N-乙酰半胱氨酸对接受腹部大手术的肝硬化患者的疗效。
Saudi J Anaesth. 2015 Jul-Sep;9(3):272-8. doi: 10.4103/1658-354X.154706.
3
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.
预测肝硬化患者急性肾损伤的发生——肾小球滤过率、蛋白尿和肾损伤生物标志物的分析。
Aliment Pharmacol Ther. 2013 May;37(10):989-97. doi: 10.1111/apt.12299. Epub 2013 Apr 12.
4
Cystatin C--a paradigm of evidence based laboratory medicine.胱抑素C——循证检验医学的典范
Clin Biochem Rev. 2008 May;29(2):47-62.